在高血压患者中,急性运动诱导的炎症和血栓反应
Charalampos I Liakos1, Constantina Aggeli2, Konstantinos P Toutouzas2
1Department of Medicine, School of Health Sciences, 1st Cardiology Clinic, Hippokration General Hospital, National and Kapodistrian University of Athens, 114 V. Sofias Avenue, 11527, Athens, Greece. bliakos@med.uoa.gr.
European journal of applied physiology
|September 9, 2024
概括
剧烈的运动在高血压患者中比在健康个体中增加了炎症和血栓标志物. 这表明,在强烈的体力活动后,高血压患者心血管事件的风险增加.
科学领域:
- 心血管生理学心血管生理学
- 运动科学 运动科学
- 高血压研究 高血压研究
背景情况:
- 剧烈的体力活动可以引发急性冠状动脉综合征,特别是在具有心血管风险因素 (如高血压) 的久坐不动的人群中.
- 关键的机制包括炎症冠状动脉斑块破裂和凝血级联激活.
研究的目的:
- 研究运动对高血压患者的炎症和血栓反应的急性影响,与正常血压患者相比.
- 评估这些群体之间的特定生物标志物的运动诱导变化的差异.
主要方法:
- 对60名未经治疗的高血压患者和65名正常血压对照进行了最大限度的跑步机运动测试,不包括具有炎症状况或冠状动脉疾病的患者.
- 血液样本在休息时和运动后立即被分析为高灵敏度C反应蛋白 (hsCRP),血清粉样蛋白A (SAA),白细胞 (WBC) 计数,介质素-6 (IL-6),总纤维素 (TF) 和等离子素激活剂抑制剂-1 (PAI-1) 活性.
主要成果:
- 所有测量的生物标志物,除了PAI-1,在运动后增加. 在这两组中,PAI-1活性显著下降.
- 在调整了运动强度和其他混因素后,高血压患者在hsCRP,SAA和WBC中表现出明显更大的运动诱导增加,与正常血压患者相比.
- 两组之间IL-6和TF水平的变化是相似的,而PAI-1降低在高血压患者中更为明显.
结论:
- 急性运动诱导的炎症和血栓反应在未经治疗的高血压患者中比在正常血压对照中更为明显.
- 这些发现表明,高血压患者对与运动有关的心血管事件的敏感性可能更高.
- 需要进一步的研究来探索这些高反应的临床影响.
相关概念视频
Exercise and Cardiovascular Response
746
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
746
Hypertension and Regulation of Blood Pressure
1.9K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.9K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
398
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
398
Exercise and Cardiac Output
943
Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
Sustained exercise increases the muscles' oxygen demand, which can be...
943
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
500
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
500
Antihypertensive Drugs: Action of β1 Blockers
320
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
320


